Schrodinger Balance Sheet
NASDAQ: SDGRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Schrodinger financial position
At the end of fiscal 2025, Schrodinger reported total assets of $726.2 million, down 11.8% from a year earlier against total liabilities of $362.1 million. Shareholders' equity stood at $364.1 million, or 50.1% of assets. The company held $230.5 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 2.75, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Schrodinger balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 230.52M | 147.33M | 155.31M | 90.47M | 120.27M | 202.30M | 25.99M |
| Short-Term Investments | 164.95M | 204.80M | 307.69M | 360.61M | 456.21M | 440.39M | 59.84M |
| Receivables | 83.04M | 235.69M | 65.99M | 55.95M | 31.74M | 31.42M | 18.68M |
| Total Current Assets | 519.26M | 634.99M | 567.80M | 533.99M | 625.06M | 682.98M | 118.54M |
| Property, Plant & Equipment | 19.46M | 24.20M | 23.32M | 14.24M | 10.03M | 5.14M | 6.27M |
| Goodwill | 4.79M | 4.79M | 4.79M | 4.79M | 0 | — | — |
| Intangible Assets | — | — | 0 | 587.00K | 0 | — | — |
| Total Assets | 726.16M | 823.23M | 802.96M | 688.59M | 756.49M | 746.26M | 155.27M |
| Accounts Payable | 11.45M | 10.67M | 16.82M | 9.47M | 8.08M | 8.40M | 3.52M |
| Total Current Liabilities | 189.14M | 191.75M | 133.67M | 108.80M | 91.21M | 73.20M | 45.02M |
| Total Liabilities | 362.11M | 401.78M | 254.40M | 240.68M | 199.40M | 122.24M | 57.01M |
| Shareholders' Equity | 364.05M | 421.44M | 548.56M | 447.89M | 557.07M | 624.01M | -93.36M |
| Retained Earnings | -628.81M | -525.54M | -338.42M | -379.14M | -229.95M | -129.56M | -105.10M |
| Net Cash (Debt) | 395.46M | 352.12M | 463.00M | 451.09M | 576.48M | 642.69M | 85.83M |
| Shares Outstanding | — | — | 62.98M | 62.16M | 61.83M | 60.71M | 6.12M |
This table shows 7 annual periods of Schrodinger's balance sheet, from FY 2025 back to FY 2019, across 15 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow SDGR's reporting calendar. What is a balance sheet?